[格列酮类药物在糖尿病治疗中的真实地位：PROactive研究之后] - Suppr

Suppr

超能文献

[The true place of glitazones in the treatment of diabetes: after the PROactive study].

作者信息

Lindberg Mats, Jørgensen Preben Holme, Kampmann Jens Peter

出版信息

Ugeskr Laeger. 2006 Jun 19;168(25):2477-9; author reply 2479-80.

PMID:16824389

Abstract

摘要

相似文献

[The true place of glitazones in the treatment of diabetes: after the PROactive study].

Ugeskr Laeger. 2006 Jun 19;168(25):2477-9; author reply 2479-80.

[Glitazones--again].

Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2707; author reply 2707.

[Glitazones in type 2 diabetes--documented risks, uncertain benefits].

Lakartidningen. 2007;104(43):3198-200.

[Glitazones critically evaluated].

Dtsch Med Wochenschr. 2007 Dec;132(49):2619. doi: 10.1055/s-2007-993106.

[Too positive comment on glitazones].

Ugeskr Laeger. 2007 Feb 19;169(8):733; author reply 733.

[Glitazones more than hypoglycemics in type 2 diabetes].

Lakartidningen. 2007;104(43):3201-3.

[Heart failure while taking glitazones--what do we know today?].

Dtsch Med Wochenschr. 2009 Jul;134(28-29):1488; author reply 1488. doi: 10.1055/s-0029-1225308. Epub 2009 Jul 1.

Glitazones in type 2 diabetes: an update.

Drug Ther Bull. 2008 Apr;46(4):25-9. doi: 10.1136/dtb.2008.03.0008.

[Don't judge all glitazones alike!].

Lakartidningen. 2007;104(43):3205.

[The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].

Kardiol Pol. 2006 Mar;64(3):322-5; discussion 325-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[The true place of glitazones in the treatment of diabetes: after the PROactive study].

Ugeskr Laeger. 2006 Jun 19;168(25):2477-9; author reply 2479-80.

[Glitazones--again].

Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2707; author reply 2707.

[Glitazones in type 2 diabetes--documented risks, uncertain benefits].

Lakartidningen. 2007;104(43):3198-200.

[Glitazones critically evaluated].

Dtsch Med Wochenschr. 2007 Dec;132(49):2619. doi: 10.1055/s-2007-993106.

[Too positive comment on glitazones].

Ugeskr Laeger. 2007 Feb 19;169(8):733; author reply 733.

[Glitazones more than hypoglycemics in type 2 diabetes].

Lakartidningen. 2007;104(43):3201-3.

[Heart failure while taking glitazones--what do we know today?].

Dtsch Med Wochenschr. 2009 Jul;134(28-29):1488; author reply 1488. doi: 10.1055/s-0029-1225308. Epub 2009 Jul 1.

Glitazones in type 2 diabetes: an update.

Drug Ther Bull. 2008 Apr;46(4):25-9. doi: 10.1136/dtb.2008.03.0008.

[Don't judge all glitazones alike!].

Lakartidningen. 2007;104(43):3205.

[The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].

Kardiol Pol. 2006 Mar;64(3):322-5; discussion 325-6.